Acute Heart Failure – Diagnostic Methods
Acute Heart Failure: Biomarkers
Acute Heart Failure: Imaging
Acute Heart Failure: Treatment
Acute Heart Failure: Pharmacotherapy
Acute Heart Failure: Non-pharmacological Treatment
Circulatory Support
Renal Replacement Therapy
Acute Heart Failure: Clinical
Coagulation and Thrombosis
Endothelial dysfunction; Clinical assessment
NASH and other ectopic lipid diseases
Chronic kidney disease and nephropathies
Diabetes; macro- and microangiopathies
Aneurysms and other non-atherosclerotic arteriopathies
Nutrition, nutraceuticals
Bariatric surgery
Lipid-lowering therapies
Anti-thrombotic therapies
Anti-inflammatory therapies
Prevention and treatment of cardiovascular disease; miscellaneous
New lipid-lowering therapies
Google Glass
Bioresorbable stents
Leadless pacemaker
Valve-in-valve procedure
Protein patch for heart muscle growth
Miniature Ventricular Assist Device
Novel Embolic Protection to Prevent Strokes
Organ Conformal Electronics
Mitral Valve Modulation and Repair
Cardiac Decellularization and Engineered Heart Tissue
Engineered Heart Valve
Artificial Intelligence to Predict Cardiac Arrhythmias
Magnetic Navigation and Robotic Systems
Pluripotent Stem Cells and Transdifferentiated Cardiomyocytes
Invasive Cardiology
Non-Invasive Cardiology
Interventional Cardiology
Coronary Intervention
Coronary Intervention: Complications
Coronary Intervention: Primary and Acute PCI
Coronary Intervention: Mechanical Circulatory Support
Coronary Intervention: Restenosis
Non-coronary Cardiac Intervention
Pharmacology and Pharmacotherapy
Cardiovascular Pharmacotherapy
Anticoagulants
Antiplatelet Drugs
Diuretics Nitrates Lipid-Lowering Agents
Anti-Diabetic Pharmacotherapy
Cardiopulmonary Physical Therapy
Cardiorespiratory Physiotherapy
Echocardiography
Intraoperative and Interventional Echocardiography
Computed Tomography
Coronary CT Angiography
Cardiac Magnetic Resonance
Nuclear Imaging
Epidemiology of cardiovascular diseases and risk factors
Epidemiology of dyslipidemias
Diabetes, insulin sensitivity and resistance
Adipose tissue homeostasis
Inherited dyslipidemias
Gender and cardiovascular risk
Environmental risk factors
Novel risk factors and biomarkers
Epidemiology of socioeconomic and psychosocial risk factors
Coagulation
Gut microbiome
Gene editing technology
Genomics, GWAS and population genetics; Mendelian randomization
Epigenetics and microRNA
Gene-Environment interactions
Arrhythmias, General
Arrhythmias, General – Treatment
Atrial Fibrillation
Atrial Fibrillation - Epidemiology, Prognosis, Outcome
Atrial Fibrillation - Treatment
Atrial Fibrillation - Stroke Prevention
Supraventricular Tachycardia (non-AF)
Supraventricular Tachycardia (non-AF) - Pathophysiology and Mechanisms
Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome
Supraventricular Tachycardia (non-AF) - Diagnostic Methods
Supraventricular Tachycardia (non-AF) - Treatment
Supraventricular Tachycardia (non-AF) - Prevention
Supraventricular Tachycardia (non-AF) - Clinical Syncope and Bradycardia
Syncope and Bradycardia - Pathophysiology and Mechanisms
Bradycardia - AV-Block
Tachycardia
Non-arrhythmogenic Mechanisms of Syncope
Syncope and Bradycardia - Diagnostic Methods
Syncope and Bradycardia - Treatment
Drug Treatment
Pacemaker Therapy
Syncope and Bradycardia - Clinical
Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
Ventricular Arrhythmias and SCD - Treatment
Management of Out of Hospital Cardiac Arrest
Device Treatment of Ventricular Arrhythmias and SCD
Ventricular Arrhythmias and SCD - Clinical
Device Therapy Device Complications and Lead Extraction
HEART–Access to Care/Caregiver
HEART–Basic Science-Immunology, Inflammation
HEART–Basic Science-Models of Organ Preservation, Perfusion and Graft Injury
HEART–Basic Science-Translational Research/Other
HEART–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs
HEART–Cardiac Allograft Vasculopathy
HEART–Cardiogenic Shock
HEART–Clinical Ex-Vivo Perfusion and Preservation
HEART–Compliance/Adherence/Psychosocial Aspects
HEART–Complications Other
HEART–Congenital Heart Disease Management
HEART–COVID 19 Vaccine Pre- and Post-Transplant
HEART–COVID-19 Non-Vaccine related
HEART–Critical Care Medicine/Peri-operative/Intra-operative Management
HEART–Diagnostics/Patient Management/Patient Care Pathways
HEART–Donor Management HEART–Economics, Ethics, Public Policy/Health Equity
HEART–Immunology, Inflammation (Clinical)
HEART–Infectious Diseases - Diagnostics and Complications
HEART–Infectious Diseases - Management and Therapeutics
HEART–Organ Allocation HEART–Other (Clinical)
HEART–Outcomes (Effectiveness)
HEART–Outcomes (Other)
HEART–Outcomes (Risk Prediction/Modelling)
HEART–Outcomes (Safety)
HEART–Palliative Care/Self Care/Symptom Management
HEART–Pathology
HEART–Patient Selection for Advanced Therapies/Rehabilitation
HEART–Pediatrics-Basic and Translational Research
HEART–Pediatrics-Complications
HEART–Pediatrics-Heart Failure
HEART–Pediatrics-Other
HEART–Pediatrics-Outcomes
HEART–Pediatrics-Patient Selection, Organ Allocation, Donor Management
HEART–Pharmacology, Therapeutics, Immunosuppression
HEART–Primary Graft Dysfunction
HEART–Quality of Life/Quality Improvement
HEART–Rejection-Antibody Mediated (AMR)
HEART–Rejection-Cellular
HEART–Telehealth/Remote Monitoring and Interventions
Hypertrophic Cardiomyopathy
Dilated Cardiomyopathy
Restrictive Cardiomyopathy
Arrhythmogenic Right Ventricular Dysplasia
Alcoholic cardiomyopathy
Congestive cardiomyopathy
Diabetic cardiomyopathy
Familial dilated cardiomyopathy
Idiopathic cardiomyopathy
Ischemic cardiomyopathy
Peripartum cardiomyopathy
Primary cardiomyopathy
Asymmetric septal hypertrophy
Familial hypertrophic cardiomyopathy
Hypertrophic nonobstructive cardiomyopathy
Hypertrophic obstructive cardiomyopathy
Idiopathic hypertrophic subaortic stenosis
Idiopathic restrictive cardiomyopathy
Infiltrative cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy
Right ventricular cardiomyopathy
Right ventricular dysplasia
Aortic Surgery
Cardiac Surgery and Arrhythmias
Cardiac Surgery and CHD and Pediatrics
Cardiac Surgery and Heart Failure
Cardiac Surgery and SIHD
Cardiac Surgery and VHD
Vascular Surgery
Coronary artery bypass grafting (CABG)
Heart valve repair or replacement
Insertion of a pacemaker or an implantable cardioverter-defibrillator (ICD).
Maze surgery
Aneurysm repair
Insertion of a ventricular assist device (VAD) or total artificial heart (TAH)
Abdominal Surgery
Experimental Surgery
Discuss COVID-19 in diabetes and Obesity
Describe the relationship between diabetes, obesity, and heart failure
Discuss T1D obesity and CVD
Discuss the role of the beta cells in diabetes
Discuss the role of fat cells in the development of cardiometabolic conditions
Explain the roles of diabetes in the development of micro & macrovascular conditions: kidney disease, retinopathy, neuropathy, CVD, and strokes
Provide the traditional comprehensive management of diabetes, addressing obesity, hypertension, dyslipidemia, and hyperglycemia
Highlight the paradigm shift in management focusing on preventing the next evet of ASCVD, HF and CKD
Discuss the role of GLP1ra in the management of diabetes, obesity, and prevention of ASCVD
Evaluate SGLT2 inhibitors role in reducing cardiovascular morbidity & mortality in patients with and without T2D and at risk for or established CVD
Address SGLT2i role in managing patients with CKD and HFrEF & HFpEF
Explain the role of PCSK9 inhibitors in preventing CV morbidity in people with established ASCVD
Discuss fatty liver disease and its relationship to diabetes and CVD
Evaluate the impact on the clinical practice of lipid CV outcome trials, including IMPROVE-IT, FOURIER, REDUCE-IT, ODYSSEY-Outcomes
Examine the impact of Coagulation in diabetes in prevention of CVD and CVA
Technology in monitoring and reducing DM & ASCVD
Address the multispecialty practice recommendations to managing patients with cardiorenalmetabolic diseases